Providing recombinant antibodies to the academic community
ABCD database release 5.0
More than 13'000 entries in our
October release. Check it here.
Publications with Abs discovered by us
Eight new sequenced hybridomas
New articles published in Antibody Reports
Check it here.
The Geneva Antibody Facility is purely academic, and does not generate any commercial profit.
All antibodies discovered and/or produced by the facility will be made available to the whole scientific community.